4//SEC Filing
BJERKHOLT ERIC 4
Accession 0001415889-25-002136
CIK 0001759425other
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 4:49 PM ET
Size
7.2 KB
Accession
0001415889-25-002136
Insider Transaction Report
Form 4
BJERKHOLT ERIC
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-01-23+2,667→ 35,946 total - Exercise/Conversion
Restricted Stock Units
2025-01-23−2,667→ 5,333 total→ Common Stock (2,667 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
- [F2]1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date.
Documents
Issuer
Mirum Pharmaceuticals, Inc.
CIK 0001759425
Entity typeother
Related Parties
1- filerCIK 0001197350
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 4:49 PM ET
- Size
- 7.2 KB